Craig L. Slingluff, MD, M.D

Rare Disease / Clinical Research

University of Virginia

CHARLOTTESVILLE, VA

PI on 5 trialsNPI: 1477687283

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Isolated femoral agenesis/hypoplasia
Germ cell tumor
Uveal melanoma
Conjunctival malignant melanoma
Dendritic cell tumor

Clinical trials (5)

NCT00705640
NCT00118274
NCT00003222
NCT00089206
NCT00089219

Verify independently

ClinicalTrials.gov PI search for Craig L. Slingluff, MD
NPPES NPI registry entry

Other specialists for Isolated femoral agenesis/hypoplasia

Peers ranked by clinical-trial PI role, publications, and verification quality.

David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Richard Kocharian, MD, PhD
Ethicon, Inc.
Anthony Shields
Barbara Ann Karmanos Cancer Institute
F. Stephen Hodi, MD
Dana-Farber Cancer Institute
Scot C. Remick, MD, MD
Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
ME
Siv Fonnes, MD
Centre for Perioperative Optimization, Department of Surgery, Herlev and Gentofte Hospitals, University of Copenhagen
Robert J Amato, DO
Baylor College of Medicine - Methodist Hospital
Paul B. Chapman, MD
Memorial Sloan Kettering Cancer Center

See all specialists for Isolated femoral agenesis/hypoplasia →

← Back to specialists directory